S&P 500
      6,913.35
      Arrow Up
      Nasdaq
      23,436.02
      Arrow Up
      B500
      2,498.10
      Arrow Up
      FTSE 100
      10,150.05
      Arrow Up
      US 10 Yr
      4.24
      Arrow Up
      Crude Oil
      59.36
      Arrow Down
      Gold
      4,913.40
      Arrow Up
      Euro
      1.18
      Arrow Down
      Pound/Dollar
      1.35
      Arrow Down
      Search
        Markets
        Data
        Search

          CEL-SCI Corp
          CVM:US

          Nyseamerican (USD)· Market closed
          6.41
          Arrow Up
          As of.Nasdaq Last Sale

          Prev. Close

          5.26 USD

          6.41 USD
          15:58
          10:3011:3012:3013:3014:3015:3016:305.005.506.006.507.00
          5.67 USD
          Jan 22
          12/2612/311/41/91/131/181/224.004.755.506.257.00
          6.41 USD
          Jan 22
          8/179/1310/911/412/112/271/220.005.0010.0015.0020.00
          5.67 USD
          Jan 22
          1/31/61/91/131/161/191/224.004.755.506.257.00
          5.67 USD
          Jan 22
          4/217/2110/211/210.005.0010.0015.0020.00
          5.15 USD
          Jan 16, 2026
          202220232024202520260.00200.00400.00600.00800.00
            Related News

            CEL-SCI Corporation operates as a biotechnology company. The Company engages in the research and development of immunotherapy products for the treatment of cancer, autoimmune, and infectious diseases. CEL-SCI offers its services across North America.

            8229 Boone Blvd Suite 802 Vienna, VA 22182 United States

            www.cel-sci.com

            Income Statement

            Annual

            Balance Sheet

            Popular Securities

            Dow Jones Industrial Average
            49,384.01USD
            Arrow Up
            S&P 500 INDEX
            6,913.35USD
            Arrow Up
            NASDAQ Composite Index
            23,436.02USD
            Arrow Up
            Before it's here, it's on the Bloomberg Terminal
            Bloomberg Terminal LEARN MORE
            View Your WatchlistArrow Right

            More from Bloomberg

            Greenland PM Tells People to Prepare for Possible Invasion

            Putin Offers Frozen Russia Assets in US to Aid Ukraine, Gaza

            Lululemon Pauses Online Sales of Sheer Leggings That Aren’t ‘Squat Proof’

            Trump Sues JPMorgan for $5 Billion Over Debanking Claims

            Supreme Court Doesn't Rule on Tariffs, With Next Potential Decision in February

            HomeBTV+Market DataOpinionAudioOriginalsMagazineEvents
            News
            MarketsEconomicsTechnologyPoliticsGreenCryptoAI
            Work & Life
            WealthPursuitsBusinessweekCityLabSportsEqualityManagement & Work
            Market Data
            StocksCommoditiesRates & BondsCurrenciesFuturesSectorsEconomic Calendar
            Explore
            NewslettersExplainersPointed News QuizAlphadots GameThe Big TakeGraphicsSubmit a TipAbout Us
            Terms of ServiceTrademarksPrivacy Policy
            CareersAdvertise
            Ad Choices
            Help©2026 Bloomberg L.P. All Rights Reserved.
            Unlock unlimited access with a Bloomberg.com subscription.
            Save now with a special offer. Just $1.99/month.
            Unlock unlimited access for $1.99/month.